Quantitative Ultrasound Assessment of Abdominal Cavity Space

October 8, 2024 updated by: Ruijin Hospital

Study on the Application Value of Quantitative Ultrasound Assessment Plan for Abdominal Cavity Space in Critically Ill Patients

This is a prospective observational study to observe the diagnostic efficacy of a quantitative ultrasound assessment plan for pathological accumulation in the abdominal cavity space of critically ill patients, and to explore its correlation with patient clinical outcomes.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Intra-abdominal lesions, such as hemorrhage and inflammation/infection, often lead to pathological accumulations, posing serious challenges for critically ill patients. These lesions can rapidly induce intra-abdominal hypertension and organ damage, which may progress to hemorrhagic or septic shock, endangering patients' lives. Intra-abdominal hemorrhage, especially surgery-related hemorrhage, is difficult to detect early, and existing assessment methods like CT scans have limited applicability in critically ill patients. Intra-abdominal infections account for a high proportion of infections in critically ill patients, with concurrent sepsis or shock having high mortality rates. Despite advancements in critical care medicine, the mortality rate from intra-abdominal infections remains stubbornly high. Accurate assessment of the source and extent of infection is crucial for treatment, yet routine physical examinations have low sensitivity in critically ill patients, making imaging examinations the primary method. However, while abdominal CT is considered the gold standard, it is limited by insufficient dynamic monitoring and difficulties in patient transport. Bedside ultrasound plays a significant role in the monitoring of critically ill patients due to its portability, non-invasiveness, and real-time dynamic capabilities. It can assess sources of hemorrhage and infection, quantify the extent of lesions, and monitor hemodynamic changes. Therefore, this study aims to develop a comprehensive ultrasound assessment protocol that covers the peritoneal cavity and posterior peritoneal space. Through a prospective observational study, we aim to validate its sensitivity and specificity in diagnosing pathological accumulations such as intra-abdominal hemorrhage/infection and explore its correlation with patient clinical outcomes.

Study Type

Observational

Enrollment (Estimated)

125

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Weiqing Zhang, Ph.D
  • Phone Number: 8618521525300
  • Email: weiq.zh@163.com

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200025
        • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Critically ill patients in the Department of Critical Care Medicine at Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University

Description

Inclusion Criteria:

  • Age > 18 years old;
  • Expected ICU stay ≥ 72 hours;
  • Meeting one of the diagnostic criteria for intra-abdominal infection: 1) Single organ infection (such as cholecystitis, appendicitis, diverticulitis, cholangitis, pancreatitis, salpingitis, etc.), which may be accompanied by or without peritonitis, even without perforation; 2) Peritonitis, classified as primary, secondary, or recurrent; 3) Intra-abdominal abscess.

Exclusion Criteria:

  • Patients with wounds, redness, swelling, bleeding, or other conditions at the abdominal measurement points that prevent ultrasound assessment;
  • Patients with intra-abdominal gas accumulation that affects abdominal ultrasound imaging, making ultrasound quantitative scoring impossible;
  • Patients who have not undergone abdominal CT examination within 72 hours of ICU admission;
  • Patients who do not consent to participate in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
observational group
Subjectives will undergo abdominal ultrasound examination immediately after receiving an abdominal CT scan.after admission to the ICU.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quantitative CT Scoring for Pathological Accumulations in the Abdominal Cavity Space
Time Frame: up to 3 days after admission to ICU
score range from 0-20, higher scores indicate a worse outcome
up to 3 days after admission to ICU
Quantitative Ultrasound Scoring for Pathological Accumulations in the Abdominal Cavity Space
Time Frame: up to 3 days after admission to ICU
score range from 0-20, higher scores indicate a worse outcome
up to 3 days after admission to ICU

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to initiate enteral nutrition
Time Frame: up to 3 days after admission to ICU
Time to initiate enteral nutrition after admission to ICU in hours
up to 3 days after admission to ICU
Intra-abdominal pressure
Time Frame: up to 3 days after admission to ICU
Intra-abdominal pressure in mmHg
up to 3 days after admission to ICU
C-reactive protein
Time Frame: up to 3 days after admission to ICU
C-reactive protein in mg/L
up to 3 days after admission to ICU
procalcitonin
Time Frame: up to 3 days after admission to ICU
procalcitonin in ng/L
up to 3 days after admission to ICU
white blood cell count
Time Frame: up to 3 days after admission to ICU
white blood cell count
up to 3 days after admission to ICU
time to achieve enteral nutrition targets
Time Frame: up to 28 days after admission to ICU
time to achieve enteral nutrition targets in hours
up to 28 days after admission to ICU
serum albumin
Time Frame: up to 28 days after admission to ICU
serum albumin in g/L
up to 28 days after admission to ICU
prealbumin
Time Frame: up to 28 days after admission to ICU
prealbumin in mg/L
up to 28 days after admission to ICU
Duration of Continuous Renal Replacement Therapy treatment
Time Frame: up to 28 days after admission to ICU
Duration of CRRT (Continuous Renal Replacement Therapy) treatment in hours
up to 28 days after admission to ICU
duration of mechanical ventilation
Time Frame: up to 28 days after admission to ICU
duration of mechanical ventilation in hours
up to 28 days after admission to ICU
length of ICU stay
Time Frame: up to 28 days after admission to ICU
length of ICU stay in days
up to 28 days after admission to ICU
prognosis
Time Frame: up to 28 days after admission to ICU
survival or death when transfer out of the ICU
up to 28 days after admission to ICU
acute physiology and chronic health evaluation II score
Time Frame: up to 3 days after admission to ICU
score range from 0-71, higher scores indicate a worse outcome
up to 3 days after admission to ICU
Sequential Organ Failure Assessment
Time Frame: up to 3 days after admission to ICU
score range from 0-15, higher scores indicate a worse outcome
up to 3 days after admission to ICU
Abdominal Gastrointestinal Index score
Time Frame: up to 3 days after admission to ICU
score range from 0-4, higher scores indicate a worse outcome
up to 3 days after admission to ICU
Abdominal Gastrointestinal Index Ultrasonography Score
Time Frame: up to 3 days after admission to ICU
score range from 0-10, higher scores indicate a worse outcome
up to 3 days after admission to ICU
Gastrointestinal Ultrasound Scoring score
Time Frame: up to 3 days after admission to ICU
score range from 0-10, higher scores indicate a worse outcome
up to 3 days after admission to ICU
semi-quantitative ultrasound score of gastric content
Time Frame: up to 3 days after admission to ICU
score range from 0-2, higher scores indicate a worse outcome
up to 3 days after admission to ICU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2024

Primary Completion (Estimated)

August 1, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

September 19, 2024

First Submitted That Met QC Criteria

October 8, 2024

First Posted (Actual)

October 10, 2024

Study Record Updates

Last Update Posted (Actual)

October 10, 2024

Last Update Submitted That Met QC Criteria

October 8, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ZWQ21886-2024-2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Subscribe